Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
zhe Hong
Observed name:
Zhe Hong
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Cancer Institute
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Cancer Institute
ORCID:
0000-0001-5942-4893
Observed ORCID:
0000-0001-5942-4893
OpenAlex ID:
A5017092769
METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation
2026
·
Ruifeng Yang
, Qintao Ge
, et al.
·
Oncogene
Correction: Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide
2026
·
Junhong Li
, Zhe Hong
, et al.
·
Oncogene
PDF
BET inhibitor blocks the oncogenic function of nucleophosmin 1 in castration-resistant prostate cancer by interfering with the c-Myc signaling pathway
2022
·
zhe Hong
, Chengdang Xu
, et al.
·
Research Square
PDF
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer
1970
·
Quanxin Wang
, Songlin Zuo
, et al.
·
Current Gene Therapy
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type